Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc. is a biotechnology company focused on developing and commercializing DNA-based immunotherapies for the treatment of cancer and infectious diseases. With a proprietary DNA medicine platform, Inovio aims to transform the way diseases are prevented and treated. The company's innovative approach utilizes synthetic DNA plasmids delivered directly into cells using electroporation, triggering an immune response to target and eliminate specific diseases. Inovio's diverse pipeline includes potential treatments for cervical dysplasia, prostate cancer, HIV, hepatitis B, and other challenging diseases.